Belgian-based KBC Group NV provides comprehensive banking, insurance services, and investment fund management.
Location
City of Brussels, Flemish Brabant, BE
Founded
1935
KBC Group NV is a Belgian financial institution focusing on comprehensive banking and insurance services. The firm's investment activities span various stages, from Series A to Series E, with a particular emphasis on early-stage investments. While specific investment sizes are not disclosed, KBC's portfolio suggests a range of investment capabilities.
Notable portfolio companies include argenx and CymaBay Therapeutics, reflecting KBC's interest in the biotechnology sector. As a full-service financial group, KBC offers a wide array of services to its portfolio companies, including banking, insurance, and investment fund management. This integrated approach allows KBC to provide holistic financial support to the businesses it invests in, leveraging its expertise across multiple financial domains.
KBC - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
